LLY
Eli Lilly and Company
LLY has the edge over OFIX overall, supported by stronger fundamentals and stronger modeled upside.
OFIX
Orthofix Medical Inc.
OFIX's outlook is improving, though it still trails on the overall score.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
OFIX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Weak |
OFIX's revenue and profitability are currently stable, but its cash flow and balance sheet are under pressure.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
OFIX PE Valuation
OFIX has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
LLY has the edge over OFIX on the outlook, with more favorable revenue expectations.
OFIX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect OFIX's losses to shrink, with revenue holding steady.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over OFIX on earnings quality, reporting a profit while its opponent remains loss making.
OFIX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.11 | +$1.93 |
| Q2 2026 | -$1.53 | +$1.65 |
| Q1 2026 | -$1.50 | +$2.20 |
| Q4 2025 | -$2.33 | +$0.97 |
| Q3 2025 | -$3.04 | +$0.07 |
| Q2 2025 | -$3.18 | -$0.01 |
| Q1 2025 | -$3.70 | -$0.34 |
| Q4 2024 | -$3.30 | +$0.82 |
OFIX is still losing money, but far less than before: $1.11 per share over the past year, against $4.12 at its worst in late 2023.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over OFIX on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over OFIX on profitability, with a higher operating margin.
OFIX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $207.9M | +1.1% |
| Q2 2026 | $210.9M | +3.8% |
| Q1 2026 | $196.7M | +1.6% |
| Q4 2025 | $219.9M | +2% |
| Q3 2025 | $205.6M | +4.6% |
| Q2 2025 | $203.1M | +2.3% |
| Q1 2025 | $193.6M | +2.7% |
| Q4 2024 | $215.7M | +7.6% |
OFIX's revenue has grown year over year for 15 quarters in a row: $208M last quarter, up 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.7% | +9 points |
| Q2 2026 | -3.9% | +4 points |
| Q1 2026 | -7.3% | +18 points |
| Q4 2025 | 0.2% | +5.5 points |
| Q3 2025 | -8.3% | +1.3 points |
| Q2 2025 | -7.9% | +4.7 points |
| Q1 2025 | -25% | -9.7 points |
| Q4 2024 | -5.3% | +3.8 points |
OFIX's operating margin was 0.7% last quarter, up 9 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over OFIX on cash generation, producing positive trailing cash flow while its opponent burns cash.
OFIX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$14.1M | -666% |
| Q2 2026 | -$18.9M | -517% |
| Q1 2026 | -$28.3M | -$3.1M |
| Q4 2025 | $16.8M | +20% |
| Q3 2025 | $2.5M | -61% |
| Q2 2025 | $4.5M | +$4.9M |
| Q1 2025 | -$25.1M | +$4M |
| Q4 2024 | $14.1M | +$35.3M |
OFIX's free cash flow was −$44M over the past year, against −$4M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over OFIX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
OFIX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +272K shares |
| 1 year | +3.6% | +1.4M shares |
| 3 years | +108% | +21.4M shares |
OFIX has 41M diluted shares, up 3.6% from a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY has the edge over OFIX on leverage, with a lower net debt burden relative to earnings.
OFIX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.2x | High |
| Q2 2026 | 8.6x | High |
| Q1 2026 | 10.8x | High |
| Q4 2022 | -3.2x | Net Cash |
| Q3 2022 | -3.0x | Net Cash |
| Q2 2022 | -2.6x | Net Cash |
| Q1 2022 | -3.4x | Net Cash |
| Q4 2021 | -4.1x | Net Cash |
OFIX's net debt is about 4.2 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
OFIX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.9 | Oversold |
| Stochastic | 8.4 | Oversold |
OFIX's weekly RSI is 30 (oversold) and its Stochastic is 8 (oversold).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
OFIX PE vs Healthcare Sector
| Metric | OFIX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
OFIX has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over OFIX on trend strength, trading above more of its moving averages.
OFIX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.85 | 22% below |
| 20 week MA | $9.71 | 29% below |
| 50 week MA | $11.4 | 39% below |
| 100 week MA | $13.0 | 47% below |
| 200 week MA | $14.5 | 52% below |
OFIX is in a downtrend: it's below all five of its weekly moving averages, and 52% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over OFIX on returns for 2026, with the stronger performance.
OFIX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.0 | $42.6 | -7.5% |
| 2021 | $42.6 | $31.5 | -26% |
| 2022 | $31.5 | $19.3 | -39% |
| 2023 | $19.3 | $13.5 | -30% |
| 2024 | $13.5 | $17.5 | +30% |
| 2025 | $17.5 | $15.2 | -13% |
| 2026 YTD | $15.2 | $6.94 | -54% |
OFIX has finished lower in five of the last six years. It's down 54% so far in 2026.